Alpha 2.0
Login Register
» Articles » PMID: 38966073

A New Era in Maternal-child Health: Abrysvo's Role in RSV Prevention

Overview
Journal Health Sci Rep
Specialty General Medicine
Date 2024 Jul 5
PMID 38966073
Authors
Ayesha Shaukat
Um E Abiha Batool
Nathalie Nasser
Affiliations
Soon will be listed here.
Citing Articles

Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue.

Li Q, Li H, Li Z, Wang Y MedComm (2020). 2024; 5(12):e70016.

PMID: 39575302 PMC: 11581781. DOI: 10.1002/mco2.70016.

References
1.
Wheeler S, Dotters-Katz S, Heine R, Grotegut C, Swamy G . Maternal Effects of Respiratory Syncytial Virus Infection during Pregnancy. Emerg Infect Dis. 2015; 21(11):1951-5. PMC: 4622246. DOI: 10.3201/eid2111.150497. View
2.
Munoz F, Swamy G, Hickman S, Agrawal S, Piedra P, Glenn G . Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants. J Infect Dis. 2019; 220(11):1802-1815. DOI: 10.1093/infdis/jiz390. View
3.
Bottino P, Miglino R, Pastrone L, Barbui A, Botta G, Zanotto E . Clinical features of respiratory syncytial virus bronchiolitis in an infant: rapid and fatal brain involvement. BMC Pediatr. 2021; 21(1):556. PMC: 8655089. DOI: 10.1186/s12887-021-03045-9. View
4.
Kampmann B, Madhi S, Munjal I, Simoes E, Pahud B, Llapur C . Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023; 388(16):1451-1464. DOI: 10.1056/NEJMoa2216480. View